NCT02142959 2025-06-03
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
Biogen
Phase 2 Completed
Clinical Trials
4 trialsNCT02500641 2019-06-21
FORWARD
Menarini International Operations Luxembourg SA
Phase 4 Completed
NCT01089998 2013-01-21
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations
Life Molecular Imaging SA
Phase 1 Completed
NCT01297088 2013-01-21
PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations.
Life Molecular Imaging SA
Phase 1 Completed